Belatacept for Renal Allograft Recipients: A Compassionate Use Program.

Trial Profile

Belatacept for Renal Allograft Recipients: A Compassionate Use Program.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Jun 2015

At a glance

  • Drugs Belatacept (Primary)
  • Indications Renal transplant rejection
  • Focus Expanded access; Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 13 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 15 Jan 2010 Actual initiation date changed from Jan 2009 to Jan 2010 as reported by ClinicalTrials.gov.
    • 10 Jun 2009 Planned end date changed from 1 Jul 2010 to 1 Jan 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top